Previous Article | Next Article ![]()
J Virol, March 1998, p. 2125-2131, Vol. 72, No. 3
Infectious Disease Laboratory, Salk Institute
for Biological Studies, La Jolla, California
92037,2 and
Gene Therapy Laboratories,
Norris Cancer Center, University of Southern California School of
Medicine, Los Angeles, California 900331
Received 15 September 1997/Accepted 25 November 1997
We have explored the requirements for host proteins in the
integration of Moloney murine leukemia virus (MoMuLV) cDNA in vitro. Following infection, it is possible to lyse cells and obtain
preintegration complexes (PICs) capable of integrating the MoMuLV cDNA
into an added target DNA in vitro (intermolecular integration). PICs
can be stripped of required proteins by gel filtration in high-salt buffers (600 mM KCl), allowing the nature of the removed factors to be
investigated by in vitro reconstitution. In a previous study of human
immunodeficiency virus type 1 (HIV-1) PICs, the host protein HMG I(Y)
was found to be able to restore activity to salt-stripped PICs. In
contrast, salt stripping and reconstitution of MoMuLV PICs led to the
proposal that a host factor is important for a different activity,
blocking integration into the cDNA itself (autointegration). In this
report, we investigated reconstitution of salt-stripped MoMuLV PICs and
found that addition of cellular extract from uninfected NIH 3T3 cells
could block autointegration and also restore intermolecular
integration. Isolation of the intermolecular integration-complementing
activity yielded HMG I(Y), as in the HIV-1 case. However, HMG I(Y)
could not block autointegration, implicating a different host factor in
this process. Additionally, when MoMuLV PICs were partially purified
but not salt stripped, the intermolecular integration activity was
reduced but could be stimulated by the addition of any of several
purified DNA binding proteins. In summary, three activities were
detected: (i) the intermolecular integration cofactor HMG I(Y), (ii) an autointegration barrier protein, and (iii) stimulatory DNA binding proteins.
An essential step in retroviral
replication is the integration of viral cDNA into host cell DNA
(11, 20, 54). In vivo, the linear viral cDNA is assembled
into large nucleoprotein complexes called preintegration complexes
(PICs) (2, 26, 44). PICs can be isolated from newly infected
cells and are capable of integrating the viral cDNA into an added
target DNA in vitro (3, 16, 21). We have used such PIC-based
assays to investigate host factors important for integration of Moloney
murine leukemia virus (MoMuLV) cDNA.
One of the components of MoMuLV PICs is inferred to be integrase.
Though the protein has not yet been detected physically in isolated
MoMuLV PICs, integrase is expected to be present, since the enzymatic
activity is essential for integration in vivo (4, 14, 50).
For human immunodeficiency virus type 1 (HIV-1), integrase has been
shown to be associated with PICs (5, 18, 23). Recombinant
integrase proteins from ASLV (avian sarcoma-leukosis virus), MoMuLV,
HIV-1, and other retroviruses have been shown to be capable of removing
2 nucleotides from 3' ends of model long terminal repeat (LTR) DNAs
(12, 30, 38, 51) and joining the resulting recessed 3'
hydroxyl group to the target DNA in vitro (8, 12, 15, 35,
37).
Purified integrase proteins differ in their abilities to carry out
coordinated joining of pairs of LTR ends, thereby generating integration intermediates with a defined spacing between points of
joining at each end of the cDNA (called coupled joining) (Fig. 1). In the case of HIV-1 integrase, only
single LTR analogs generally become joined to target DNA, mimicking
events at one cDNA end only (7, 8). More-efficient coupled
joining is seen when lysed HIV-1 virions are used as a source of
integrase (29). Purified MoMuLV and ASLV integrases yield
coupled products more efficiently than does integrase of HIV (1,
12, 24, 37, 55).
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Modulation of Activity of Moloney Murine Leukemia
Virus Preintegration Complexes by Host Factors In Vitro

![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (18K):
[in a new window]
FIG. 1.
Inferred pathway for intermolecular integration and
autointegration. MoMuLV cDNA (thin lines) and target DNA (thick lines)
are indicated. The 5' ends (small solid circles) and 3' ends (arrows)
are indicated. II, integration intermediate.
Unlike purified integrase, reactions with PICs yield coupled integration products as the only detectable forms, producing the integration intermediate (II) illustrated in Fig. 1 (3, 16, 21). Integration is thought to be completed in vivo by host DNA repair enzymes which connect the remaining unjoined strands in the integration intermediate and complete proviral synthesis.
Several previous studies have outlined the organization and composition of PICs. In the case of MoMuLV, PICs are known to be large particles (around 160S) potentially containing several viral proteins (2). In the case of HIV-1, the linear viral cDNA is packaged into a large particle with a diameter of 54 nm as estimated by gel filtration (for comparison, the diameter of a virion is about 120 nm) (44). The ends of the cDNA in PICs are protected from exonuclease digestion by bound proteins (44). The two ends of viral cDNA appear to be held together by a protein bridge, since the cDNA can be cleaved internally without disrupting coordinated integration of the two cDNA ends (44). Of the viral proteins, integrase, reverse transcriptase (RT), matrix (MA) and Vpr proteins have been proposed to be the components of PICs and NC protein has been detected in some studies (5, 23, 28, 32, 44). In addition, a host protein, HMG I(Y) was found to be present in HIV-1 PICs and required for function in vitro (18). In that study, a salt-stripping procedure was used to remove a subset of proteins from HIV-1 PICs, which abolished intermolecular integration activity. Human HMG I(Y) protein was found to restore the activity (18).
A salt-stripping method was used previously to identify a host activity involved in the function of MoMuLV PICs (41). Salt-stripped PICs of MoMuLV not only lose normal intermolecular integration activity but also carry out autointegration, a suicidal intramolecular integration reaction in which the PIC uses its own cDNA as an integration target (41). As a result of autointegration, the linear viral cDNA becomes circularized and biologically inactivated (22, 41) (Fig. 1, autointegration). It was found that an extract from uninfected host cells could block autointegration and restore intermolecular integration activity, implicating an as yet unidentified host factor or factors (41).
Here we have isolated a factor that stimulates intermolecular integration by salt-stripped MoMuLV PICs and found the factor to be murine HMG I(Y). We have determined that murine HMG I(Y) is not itself the autointegration barrier factor. Furthermore, we investigated stimulation by additional DNA binding proteins in different experimental settings. These data identify several activities important for function of MoMuLV PICs in vitro.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. Proteins were obtained from the following sources: Escherichia coli single-stranded DNA binding protein (SSB), Stratagene; T4 gene 32 protein, Boehringer Mannheim; and RNase A, Qiagen. HIV-1MN p7 was obtained through the AIDS Research and Reference Reagent Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health from Louis Henderson (39, 52).
PIC preparation.
PICs were prepared as described previously
(3, 27) with some modifications. Plasmid pMoMuLV-K, which
contains a complete genome of MoMuLV, was obtained from A. Dusty
Miller. The plasmid was transfected into NIH 3T3 cells, and MoMuLV was
harvested 2 days later. Fresh NIH 3T3 cells were infected by the virus
and passaged to establish a chronically infected cell line. The
infected cells (2.4 × 106 cells) were plated together
with uninfected NIH 3T3 cells (9.6 × 106) in a
150-mm-diameter dish. Cells were harvested after 16 h of coculture
by trypsinization. The trypsinized cells were washed twice with buffer
A (20 mM HEPES-NaOH [pH 7.4], 150 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol) and then lysed with 450 µl of buffer A containing
0.025% digitonin (Calbiochem) and 2 µg of aprotinin (Calbiochem) per
ml. The lysate containing PICs was clarified by centrifugation as
described previously (27). The crude extract, which contains
approximately 10 ng of viral cDNA per ml and 6 mg of protein per ml was
frozen in liquid nitrogen and stored at
70°C. All the cells were
grown in Dulbecco modified Eagle's medium with 10% fetal calf serum
(Hyclone).
70°C.
Salt-stripping of PICs. One milliliter of crude PICs was partially purified by low-ionic-strength precipitation as described previously (19), except that 8,000 × g instead of 2,000 × g was used to pellet PICs. After low-ionic-strength precipitation, 80 to 90% of PICs could be recovered. After the PIC pellet was suspended in buffer A, 30% of the PICs could carry out intermolecular integration and no autointegration was detected. The protein concentration of the partially purified PICs was ~0.18 mg/ml, and the concentration of viral DNA was ~8 ng/ml.
To carry out high salt depletion, the pelleted PICs were suspended in 680 µl of buffer A with 600 mM KCl and incubated at room temperature for 10 min. The PICs were then subjected to gel filtration through Sepharose CL-4B spin columns equilibrated in buffer A with 600 mM KCl. The resulting salt-stripped PICs were concentrated by a Centricon-100 to a final volume of 50 to 100 µl. The concentrated salt-stripped PICs were then diluted to the desired volume with buffer A containing 600 mM KCl. Upon dilution to 150 mM KCl, the salt-stripped PICs lacked intermolecular integration activity and 10 to 15% of the PICs had autointegration activity.Integration assay.
The integration assay was carried out in
buffer A with 30% glycerol and 10 µg of linearized
X174 RFI per
ml. The reaction mixture was incubated at 37°C for 30 min. In the
assay for complementing activity, the cellular extract or purified
protein was incubated with salt-stripped PICs at room temperature for
10 min. The reaction buffer was then adjusted to the condition
described above and further incubated at room temperature for 10 min.
Linearized
X174 RFI was added last, and the reaction mixture was
incubated at 37°C for 30 min.
Uninfected NIH 3T3 cell extract. The cytoplasmic and nuclear extracts of NIH 3T3 cells were prepared as described previously (13). The protein concentration of each extract was adjusted to ~4 µg/µl.
Purification of HMG proteins. Uninfected NIH 3T3 cells (2 × 109) cells were scraped from 150-mm-diameter dishes, and HMG proteins were purified as described previously (18). The His-tagged HMG I(Y) was purified as described previously (18). HMG I and HMG Y are transcribed from the same gene but differ by an internal splice that removes 11 amino acids from HMG I to yield HMG Y (25). The two proteins usually cofractionate and function identically. Therefore, they are referred to together as HMG I(Y). The His-tagged variant described above actually encodes HMG I only.
For purification of HMG-1 [note that HMG I(Y) and HMG-1 are unrelated in sequence and function despite the similarity in names], pET11d-His-HMG-1 (a kind gift of Hui Ge) was transformed into HMS174(DE3) (Novagen). The bacteria containing pET11d-His-HMG-1 were grown to mid-log phase and induced by isopropyl-
-D-thiogalactopyranoside (IPTG) at a final
concentration of 1 mM. After 2 h of growth at 37°C, the bacteria
were harvested and His-tagged HMG-1 was purified as described by the
manufacturer (Novagen).
| |
RESULTS |
|---|
|
|
|---|
Depletion of required factors from MoMuLV PICs with high
concentrations of salt.
To investigate host activities involved in
integration, a salt-stripping protocol was tested to determine whether
it removed factors required for integration by MoMuLV PICs, as
had previously been observed for HIV-1 PICs (18).
MoMuLV PICs were prepared from newly infected cells as described
previously (3, 27) and partially purified by precipitation
in the presence of low-ionic-strength buffers (75 mM KCl). Thirty
percent of the partially purified PICs could integrate their viral cDNA
into added
X174 target DNA, and no autointegration activity was
detected (Fig. 2B, lane 2; see Fig. 3A,
lane 1, also). To deplete the partially purified PICs of protein
factors, low-salt-precipitated PICs were suspended in high-salt buffer
(600 mM KCl) and subjected to gel filtration through Sepharose CL-4B in
600 mM KCl. Complexes such as PICs with a molecular mass greater than
2 × 107 Da passed through the column but free
proteins were retained.
|
X174 target DNA
(Fig. 2B, compare lanes 3 and 4). These results indicated that the
salt-stripping process removed factors required both for the protection
of viral cDNA from autointegration and for efficient intermolecular
integration.
Analysis of reaction products by cleavage with restriction
enzymes.
To verify that the DNA products were those illustrated in
Fig. 1, the structures of the reaction products were probed by cleavage with restriction enzymes (Fig. 2C and D). HindIII
cleaves MoMuLV cDNA once but does not cut the
X174 target DNA.
BamHI cleaves MoMuLV cDNA three times but does not cleave
the target. Reaction products made with (Fig. 2, lanes 2 and 4) or
without target DNA (Fig. 2, lanes 1 and 3) were digested with
HindIII (Fig. 2C) or BamHI (Fig. 2D). The
sizes of fragments expected to be detected by the LTR probe are shown
in Fig. 2A, and sizes detected on Southern blots are shown beside the
autoradiograms. Note that the expected autointegration product
described is the inverted-circle form. A second autointegration
product, pairs of DNA circles, are not detected by this method (see
Materials and Methods and reference 22 for details).
All the DNA sizes observed in Fig. 2B to D are as expected by the model
in Fig. 1 and Fig. 2A, indicating that the observed DNA bands are
likely the expected intermolecular integration and autointegration
products. A similar analysis of MoMuLV autointegration by cleavage with
BamHI was published previously (41).
Reconstitution of salt-stripped PICs with host cell extract. The nature of the factor(s) required to restore intermolecular integration and block autointegration was then investigated. Cytoplasmic or nuclear extract from NIH 3T3 cells was used to reconstitute salt-stripped PICs (Fig. 3A, lanes 3 to 8). Each extract was able to restore intermolecular integration (indicated by the arrow labeled II) and showed some ability to block autointegration.
|
The intermolecular integration-complementing activity binds DNA. To test whether the activity required to reconstitute salt-stripped PICs was a DNA binding protein, depletion tests were carried out. Nuclear extract from uninfected cells was incubated with cellulose, single-stranded DNA-cellulose, or double-stranded DNA-cellulose. The cellulose was then removed by centrifugation, and the remaining supernatant was used to complement salt-stripped PICs. The nuclear extract depleted by cellulose could complement intermolecular integration (Fig. 3B, lane 3). However, extract depleted by single- or double-stranded DNA-cellulose failed to complement (Fig. 3B, lanes 4 and 5). Evidently the complementing activity is contributed at least in part by a DNA binding protein, particularly one that can bind both single- and double-stranded DNA.
Analysis of the target of the complementing activity by
order-of-addition experiments.
To investigate whether the
complementing factor acts on the salt-stripped PIC or the target DNA,
an order-of-addition experiment was performed. The salt-stripped PICs
were incubated with nuclear extract either before or after addition of
target DNA. Note that the
X174 target DNA was present in great
excess over viral DNA (10 µg/ml versus 8 ng/ml), so the
X174 DNA
can act as a sink for added DNA-binding factors as well as an
integration target. Premixing target DNA with complementing nuclear
extract substantially reduced intermolecular integration upon addition
of salt-stripped PICs (Fig. 4, compare
lanes 2 to 4 with lanes 5 to 7). These findings support a model in
which the complementing activity acts on PICs and not on target DNA.
|
Fractionation of HMG proteins in NIH 3T3 extract identified HMG I(Y) as the intermolecular integration-complementing factor. Since the factor restoring activity to salt-stripped PICs of HIV-1 was also a DNA binding protein and proved to be an HMG protein (18), HMG proteins were tested for the ability to complement salt-stripped MoMuLV PICs. Total HMG proteins were extracted from NIH 3T3 cells with 5% perchloric acid and loaded onto a Mono-S ion-exchange column. The column was eluted with a NaCl concentration gradient. Fractions were analyzed for complementing activity (Fig. 5A) and for protein content by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis followed by staining with Coomassie brilliant blue (Fig. 5B). Fractions 20 and 22 complemented intermolecular integration activity of salt-stripped PICs (Fig. 5A, lanes 10 and 11).
|
Complementation with purified proteins. To confirm that HMG I(Y) was the intermolecular integration-complementing activity, recombinant HMG I(Y) protein was purified after overexpression in bacteria and tested. In this experiment, HMG I(Y) was attached to a hexahistidine tag for convenient purification [named (HT)HMG I(Y)]. In the presence of the purified (HT)HMG I(Y), the intermolecular integration activity of salt-stripped PICs was partially restored (Fig. 6, lanes 2 to 4). However, (HT)HMG I(Y) had consistently lower complementing activity than uninfected-cell nuclear extract. Ten microliters of nuclear extract, which contained only 15 ng of HMG I(Y) (Fig. 3A, lane 6), was sufficient for maximal reconstitution of intermolecular integration activity, while 1 µg of (HT)HMG I(Y) was required (Fig. 6, lane 3). In addition, the maximal achievable activity was lower with (HT)HMG I(Y).
|
A separate requirement for blocking autointegration. Several observations indicate that the activity that restores intermolecular integration is different from the previously reported factor (41) that blocks autointegration. (i) Although nuclear extract complemented salt-stripped PICs as well as cytoplasmic extract, nuclear extract had much higher autointegration blocking activity (2 µl of nuclear extract could reduce autointegration from 14 to 8%, while 2 µl of cytoplasmic extract had no detectable effect on autointegration [both extracts at 4 µg/µl] [Fig. 3A]). These results suggested that different factors were responsible for each activity. (ii) DNA cellulose depleted the integration-complementing activity more efficiently than the autointegration-blocking activity (Fig. 3B). (iii) Upon fractionation of HMG proteins (Fig. 5), although fractions capable of complementing intermolecular integration by salt-stripped PICs were found, no clear autointegration-blocking activity was detected apart from inhibition of both reactions by histone H1. (iv) (HT)HMG I(Y) from a bacterial expression system could restore the intermolecular integration activity but could not block autointegration (Fig. 6, lanes 2 to 4).
Stimulation of intermolecular integration by DNA binding proteins. In addition, another assay method revealed a different response to added DNA binding proteins. The activity of partially purified PICs which were not salt stripped was found in some cases to be reduced. However, the activity of such complexes could be stimulated by addition of any of several different DNA binding proteins. This observation may parallel previous reports of many DNA binding proteins stimulating the activity of purified integrase proteins in vitro (1, 6, 8, 10, 26, 36, 43).
To test for stimulatory factors, PICs were obtained from a cytoplasmic fraction by hypotonic lysis and subjected to gel filtration through Sepharose CL-4B in 150 mM KCl. Such PICs displayed low intermolecular integration activity (roughly 7% integration compared to the usual 30%). However, when these complexes were incubated with selected purified DNA binding proteins, the intermolecular integration activity was increased (Fig. 7). In the case of HMG I(Y), 1 µg of the protein stimulated the reaction twofold (Fig. 7, lane 3). Addition of 5 µg of the protein was inhibitory (Fig. 7, lane 2). HMG-1 and HIV-1 NC displayed threefold stimulation (Fig. 7, lanes 5 to 12). Several single-stranded binding proteins (RNase A and E. coli SSB [Fig. 7, lanes 13 to 20] and phage T4 gene 32 protein [data not shown]) were also tested, since they were previously found to stimulate the activity of purified MoMuLV integrase protein in vitro (12a). At the highest concentration, the integration activity was increased by 1.5- to twofold (Fig. 7, lanes 13 to 20). Addition of bovine serum albumin did not stimulate the reaction (Fig. 7, lanes 21 to 24), indicating that simply increasing the bulk protein concentration did not account for the observed stimulation. Similar results were obtained (data not shown) when PICs were partially purified by a different method (digitonin lysis followed by low-ionic-strength precipitation and gel filtration through Sepharose CL-4B in 150 mM KCl). The observed diversity of DNA binding proteins that satisfy this requirement is in contrast to the strict requirement for HMG I(Y) in reconstituting intermolecular integration by salt-stripped PICs.
|
| |
DISCUSSION |
|---|
|
|
|---|
Here we report the isolation of a factor that restores intermolecular integration by salt-stripped MoMuLV PICs and its identification as murine HMG I(Y). A requirement for human HMG I(Y) was reported previously for HIV-1 PICs (18). The previously described autointegration barrier factor (41) was also detected in our experiments and found to be separate from HMG I(Y). We also identified another activity. When PICs were partially purified but were not salt stripped, they often had reduced intermolecular integration activity. This reduced activity permitted another approach to reconstitution, which revealed a requirement that could be satisfied by several different DNA binding proteins.
Possible roles of HMG I(Y). The mechanism by which HMG I(Y) complements the intermolecular integration by salt-stripped PICs is unclear, although several models can be proposed based on previous work. HMG I(Y) binds A/T-rich DNA sequences and such sequences are present in the LTRs of MoMuLV and HIV-1 (17, 42, 48, 49, 53). Each HMG I(Y) monomer has three DNA binding motifs (48) and one HMG I(Y) molecule can bridge two DNAs by binding to sites on each (33), leading to the possibility that HMG I(Y) acts by bringing distant DNA domains into proximity.
One possible model is that one HMG I(Y) molecule binds both viral cDNA and target DNA, thus bridging the PIC and target. However, a study of 61 integration sites generated by HIV-1 infection did not show an enrichment for HMG I(Y) binding sites near integration sites (10a), which is evidence against this model. Furthermore, the order-of-addition experiment in Fig. 4 also indicates that HMG I(Y) probably acts on PICs and not on target DNA. An attractive model holds that HMG I(Y) may serve as an architectural element for the formation of active PICs, helping shape the DNA for optimal function. Host DNA binding proteins have been shown to serve as architectural elements in the assembly of recombination complexes in several well-studied site-specific recombination and transposition systems (31, 40, 45). In addition, HMG I(Y) itself has been proposed to serve as an architectural element in the assembly of transcription complexes (for a review see reference 9).HMG I(Y) protein is not the autointegration barrier activity. Our data indicate that HMG I(Y) is not the autointegration barrier activity. Fractionation of murine HMG proteins yielded an activity that stimulated intermolecular integration by salt-stripped PICs, but no activity that redirected autointegration to intermolecular integration was seen. Purified HMG I(Y) could restore intermolecular integration activity of salt-stripped PICs but could not block autointegration. In addition, the relative amounts of the two activities differed in nuclear and cytoplasmic fractions of uninfected host cells, consistent with different factors accounting for each.
Stimulation of partially purified PICs by diverse DNA binding proteins. We found that MoMuLV PICs that had been partially purified but not salt stripped were often diminished in intermolecular integration activity, and the activity could be boosted two- to fourfold by addition of any of several DNA binding proteins. RNase A, T4 gene 32 protein, E. coli SSB, HMG I(Y), HIV-1 NC, and HMG-1 all supported this activity. This stimulation is distinct from the reconstitution of intermolecular integration activity of salt-stripped PICs, since only HMG I(Y) could reconstitute in this setting. Of the proteins that stimulated PICs in the two assays, so far only HMG I(Y) has been found in association with PICs (in the HIV-1 system [18]). Similar composition studies have not yet been possible in the MoMuLV system.
It is unclear how these diverse DNA binding proteins promote integration in vitro. Previously many of these proteins have been found to stimulate reactions with purified integrase proteins. Purified MoMuLV integrase was stimulated 3 to 13-fold by E. coli SSB, RNase A, and T4 gene 32 protein (12a), purified ASLV integrase was stimulated two- to fourfold by HMG-1 and HU proteins (1), and purified HIV-1 integrase was stimulated very strongly by NC protein (10), two- to fourfold by RNase T1 (43), 10 to 20-fold by Ini-1 (36), and strongly by a cocktail of DNA binding proteins (8). The fact that so many proteins support this activity raises the possibility that the mechanism involves nonselective coating of DNA, perhaps by shielding negative charges on the DNA phosphates (though for a different view, see reference 1). It will be of interest to determine whether this activity is important for integration in vivo and, if so, what proteins are involved.Possible further host activities important for the function of PICs. HMG I(Y) purified after overexpression in E. coli was less active for complementation than extracts from uninfected NIH 3T3 cells, raising the possibility that still other factors are involved. Furthermore, in the HIV-1 case, purified HMG I(Y) also did not reconstitute activity as well as crude extracts did (18). The complementation experiments illustrated in Fig. 6 used human HMG I, not murine HMG I which differs from human HMG I at two amino acid positions (34). Therefore, it is also possible that this difference explains the discrepancy in activities. HMG I(Y) has been reported to be posttranslationally modified by glycosylation, phosphorylation, acetylation, methylation, and adenylation (46, 47). Possibly, the lack of posttranslational modifications in the purified HMG I(Y) accounts for the low complementing activity. Alternatively, further protein factors may be involved. The methods for stripping and reconstituting PICs described offer an approach to identifying possible additional factors.
| |
ACKNOWLEDGMENTS |
|---|
We thank members of the Bushman lab and Leonard Evans, Mike Januzeski, Paula Cannon, and Amy Lin for suggestions and comments on the manuscript; S. Goff, A. Dusty Miller, and Hung Fan for MoMuLV cDNA; and Hui Ge for the HMG-1 expression vector.
This work was supported by Genetic Therapy Inc./Novartis and by grants AI34786 and AI37489 to F.D.B. F.D.B. is a Scholar of the Leukemia Society of America.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Infectious Disease Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (619) 453-4100. Fax: (619) 554-0341. E-mail: rick_bushman{at}qm.salk.edu.
Present address: Bio-Mega Research Division of Boehringer
Ingelheim, Canada, Ltd., Laval, Quebec H7S 2G5, Canada.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aiyar, A., P. Hindmarsh, A. M. Skalka, and J. Leis. 1996. Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J. Virol. 70:3571-3580[Abstract]. |
| 2. |
Bowerman, B.,
P. O. Brown,
J. M. Bishop, and H. E. Varmus.
1989.
A nucleoprotein complex mediates the integration of retroviral DNA.
Genes Dev.
3:469-478 |
| 3. | Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell 49:347-356[Medline]. |
| 4. |
Brown, P. O.,
B. Bowerman,
H. E. Varmus, and J. M. Bishop.
1989.
Retroviral integration: structure of the initial covalent complex and its precursor, and a role for the viral IN protein.
Proc. Natl. Acad. Sci. USA
86:2525-2529 |
| 5. |
Bukrinsky, M. I.,
N. Sharova,
T. L. McDonald,
T. Pushkarskaya,
G. W. Tarpley, and M. Stevenson.
1993.
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.
Proc. Natl. Acad. Sci. USA
90:6125-6129 |
| 6. |
Bushman, F. D., and R. Craigie.
1990.
Sequence requirements for integration of Moloney murine leukemia virus DNA in vitro.
J. Virol.
64:5645-5648 |
| 7. |
Bushman, F. D., and R. Craigie.
1991.
Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.
Proc. Natl. Acad. Sci. USA
88:1339-1343 |
| 8. |
Bushman, F. D.,
T. Fujiwara, and R. Craigie.
1990.
Retroviral DNA integration directed by HIV integration protein in vitro.
Science
249:1555-1558 |
| 9. |
Bustin, M., and R. Reeves.
1996.
High-mobility-group chromosomal proteins: architectural components that facilitate chromatin Function.
Prog. Nucleic Acid Res. Mol. Biol.
![]() :35-100.
|
| 10. | Carteau, S., S. C. Batson, L. Poljak, J.-F. Mouscadet, H. Rocquigny, J.-L. Darlix, B. P. Roques, E. Kas, and C. Auclair. 1997. Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro. J. Virol. 71:6225-6229[Abstract]. |
| 10a. | Carteau, S., C. Hoffmann, and F. D. Bushman. Submitted for publication. |
| 11. | Coffin, J. M. 1996. Retroviridae: the viruses and their replication, p. 1767-1848. In B. N. Fields, D. M. Knipe, and R. M. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 12. | Craigie, R., T. Fujiwara, and F. Bushman. 1990. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62:829-837[Medline]. |
| 12a. | Craigie, R., and F. D. Bushman. Unpublished data. |
| 13. | Dignam, J. D., P. L. Martin, B. S. Shastry, and R. G. Roeder. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol. 101:582-598[Medline]. |
| 14. |
Donehower, L. A., and H. E. Varmus.
1984.
A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration.
Proc. Natl. Acad. Sci. USA
81:6461-6465 |
| 15. | Dotan, I., B. P. Scottoline, T. S. Heuer, and P. T. Brown. 1995. Characterization of recombinant murine leukemia virus integrase. J. Virol. 69:456-468[Abstract]. |
| 16. |
Ellison, V. H.,
H. Abrams,
T. Roe,
J. Lifson, and P. O. Brown.
1990.
Human immunodeficiency virus integration in a cell-free system.
J. Virol.
64:2711-2715 |
| 17. | Elton, T. S., M. S. Nissen, and R. Reeves. 1987. Specific A · T sequence binding of RP-HPLC purified HMG-I. Biochem. Biophys. Res. Commun. 143:260-265[Medline]. |
| 18. | Farnet, C., and F. D. Bushman. 1997. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88:1-20[Medline]. |
| 18a. | Farnet, C., and F. D. Bushman. Unpublished data. |
| 19. |
Farnet, C.,
R. Lipford,
B. Wang, and F. D. Bushman.
1996.
Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules.
Proc. Natl. Acad. Sci. USA
93:9742-9747 |
| 20. | Farnet, C. M., and F. D. Bushman. 1996. HIV cDNA integration: molecular biology and inhibitor development. AIDS 10(Suppl. A):3-11. |
| 21. |
Farnet, C. M., and W. A. Haseltine.
1990.
Integration of human immunodeficiency virus type 1 DNA in vitro.
Proc. Natl. Acad. Sci USA
87:4164-4168 |
| 22. |
Farnet, C. M., and W. A. Haseltine.
1991.
Circularization of human immunodeficiency virus type 1 DNA in vitro.
J. Virol.
65:6942-6952 |
| 23. |
Farnet, C. M., and W. A. Haseltine.
1991.
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.
J. Virol.
65:1910-1915 |
| 24. |
Fitzgerald, M. L.,
A. C. Vora,
W. G. Zeh, and D. P. Grandgenett.
1992.
Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase.
J. Virol.
66:6257-6263 |
| 25. |
Friedmann, M.,
L. T. Holth,
H. Zoghbi, and R. Reeves.
1993.
Organization, inducible-expression, and chromosome localization of the human HMG I(Y) nonhistone protein gene.
Nucleic Acids Res.
21:4259-4267 |
| 26. |
Fujiwara, T., and R. Craigie.
1989.
Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration.
Proc. Natl. Acad. Sci. USA
86:3065-3069 |
| 27. | Fujiwara, T., and K. Mizuuchi. 1988. Retroviral DNA integration: structure of an integration intermediate. Cell 54:497-504[Medline]. |
| 28. | Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 17:569-576. |
| 29. | Goodarzi, G., G.-J. Im, K. Brackmann, and D. Grandgenett. 1995. Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase. J. Virol. 69:6090-6097[Abstract]. |
| 30. | Grandgenett, D. P., A. C. Vora, and R. D. Schiff. 1978. A 32,000-dalton nucleic acid-binding protein from avian retrovirus cores possesses DNA endonuclease activity. Virology 89:119-132[Medline]. |
| 31. |
Heichman, K. A., and R. C. Johnson.
1990.
The Hin invertosome: protein-mediated joining of distant recombination sites at the enhancer.
Science
249:511-517 |
| 32. |
Heinzinger, N. K.,
M. I. Bukrinsky,
S. A. Haggerty,
A. M. Ragland,
V. Kewalramani,
M.-A. Lee,
H. E. Gendelman,
L. Ratner,
M. Stevenson, and M. Emerman.
1994.
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.
Proc. Natl. Acad. Sci. USA
91:7311-7315 |
| 33. | Huth, J. R., C. A. Bewley, M. S. Nissen, J. N. S. Evans, R. Reeves, A. M. Gronenborn, and G. M. Clore. 1997. The solution structure of an HMG I(Y)-DNA complex defines a new architectural minor groove binding motif. Nature Struct. Biol. 4:657-665[Medline]. |
| 34. |
Johnson, K. R.,
D. A. Lehn,
T. S. Elton,
P. J. Barr, and R. Reeves.
1988.
Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG I(Y).
J. Biol. Chem.
263:18338-18342 |
| 35. |
Jonsson, C. B.,
G. A. Donzella, and M. J. Roth.
1993.
Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli.
J. Biol. Chem.
268:1-8 |
| 36. |
Kalpana, G. V.,
S. Marmon,
W. Wang,
G. R. Crabtree, and S. P. Goff.
1994.
Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.
Science
266:2002-2006 |
| 37. | Katz, R. A., G. Merkel, J. Kulkosky, J. Leis, and A. M. Skalka. 1990. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63:87-95[Medline]. |
| 38. |
Katzman, M.,
R. A. Katz,
A. M. Skalka, and J. Leis.
1989.
The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.
J. Virol.
63:5319-5327 |
| 39. | Lam, W.-C., A. H. Maki, J. R. Casas-Finet, J. W. Erickson, B. P. Kane, R. C. Sowder, and L. E. Henderson. 1994. Phosphorescence and optically detected magnetic resonance investigation of the binding of the nucleocapsid protein of the human immunodeficiency virus type 1 and related peptides to RNA. Biochemistry 33:10693-10700[Medline]. |
| 40. | Lavoie, B. D., G. S. Shaw, A. Millner, and G. Chaconas. 1996. Anatomy of a Flexer-DNA complex inside a higher-order transposition intermediate. Cell 85:761-771[Medline]. |
| 41. |
Lee, M. S., and R. Craigie.
1994.
Protection of retroviral DNA from autointegration: involvement of a cellular factor.
Proc. Natl. Acad. Sci. USA
91:9823-9827 |
| 42. |
Maher, J. F., and D. Nathans.
1996.
Multivalent DNA-binding properties of the HMG-I proteins.
Proc. Natl. Acad. Sci. USA
93:6716-6720 |
| 43. | Miller, M., Y.-C. Bor, and F. D. Bushman. 1995. Target DNA capture by HIV-1 integration complexes. Curr. Biol. 5:1047-1056[Medline]. |
| 44. | Miller, M. D., C. M. Farnet, and F. D. Bushman. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:5382-5390[Abstract]. |
| 45. |
Nash, H. A.
1990.
Bending and supercoiling of DNA at the attachment site of bacteriophage .
Trends Biochem. Sci.
15:222-227[Medline].
|
| 46. |
Nissen, M. S.,
T. A. Langan, and R. Reeves.
1991.
Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group-I nonhistone chromatin protein.
J. Biol. Chem.
266:19945-19952 |
| 47. |
Reeves, R.,
T. A. Langan, and M. S. Nissen.
1991.
Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity.
Proc. Natl. Acad. Sci. USA
88:1671-1675 |
| 48. |
Reeves, R., and M. S. Nissen.
1990.
The A · T-binding domain of mammalian high mobility group I chromosomal proteins.
J. Biol. Chem.
265:8573-8582 |
| 49. | Reeves, R., and A. P. Wolffe. 1996. Substrate structure influences binding of the non-histone protein HMG I(Y) to free and nucleosomal DNA. Biochemistry 35:5063-5074[Medline]. |
| 50. | Schwartzberg, P., J. Colecilli, and S. P. Goff. 1984. Construction and analysis of deletion mutations in the pol gene of Moloney murine leukemia virus: a new viral function required for productive infection. Cell 37:1043-1052[Medline]. |
| 51. |
Sherman, P. A., and J. A. Fyfe.
1990.
Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.
Proc. Natl. Acad. Sci. USA
87:5119-5123 |
| 52. | South, T. L., P. R. Blake, R. C. Sowder, L. O. Arthur, L. E. Henderson, and M. F. Summers. 1990. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry 29:7786-7789[Medline]. |
| 53. | Strauss, F., and A. Varshavsky. 1984. A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome. Cell 37:889-901[Medline]. |
| 54. | Varmus, H. E., and P. O. Brown. 1989. Retroviruses, p. 53-108. In D. E. Berg, and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C. |
| 55. | Vora, A. C., and D. P. Grandgenett. 1995. Assembly and catalytic properties of retrovirus integrase-DNA complexes capable of efficiently performing concerted integration. J. Virol. 69:7483-7488[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|